Skip to main content
SpringerLink
Log in
Book cover

Prevention of Kidney Disease and Long-Term Survival

  • Book
  • © 1982

Overview

Editors:
  1. Morrell M. Avram

    1. The Avram Center for Kidney Diseases, Division of Nephrology, The Long Island College Hospital, Brooklyn, USA
      Department of Medicine, Downstate Medical Center, Brooklyn, USA
      Brooklyn Kidney Center and Nephrology Foundation of Brooklyn, Brooklyn, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (26 chapters)

  1. Front Matter

    Pages i-xx
    Download chapter PDF

  2. Nutrition and Divalent Ion in Retarding Progression

    1. Front Matter

      Pages 1-2
      Download chapter PDF

    2. Low-Protein Diets and the Nondialyzed Uremic Patient

      • Joel D. Kopple, Charlotte E. Roberts, Gerald P. Grodstein, Gaurang M. Shah, Robert L. Winer, Warren D. Davidson et al.
      Pages 3-22

    3. Delay of Progression of Renal Failure

      • Mackenzie Walser
      Pages 23-29

    4. Phosphate and Prevention of Renal Failure

      • Allen C. Alfrey, Robert C. Tomford
      Pages 31-38

    5. Improvement of Acidosis in Long-Term Dietary Treatment of Chronic Renal Failure

      • Carmelo Giordano
      Pages 39-42

  3. Glomerular Damage and Its Prevention

    1. Front Matter

      Pages 43-44
      Download chapter PDF

    2. Hyperfiltration as a Major Causative Factor in Initiation and Progression of Glomerulosclerosis

      • Thomas H. Hostetter, Helmut G. Rennke, Barry M. Brenner
      Pages 45-54

    3. Aggravation of Glomerulonephritis by Hypertension

      • David S. Baldwin
      Pages 55-65

  4. Genesis and Prevention of Diabetic Nephropathy

    1. Front Matter

      Pages 67-68
      Download chapter PDF

    2. Relationship between Hyperglycemia and Diabetic Glomerulosclerosis

      • Celia S. Levitz, Sondra R. Hirsch, Eli A. Friedman
      Pages 69-79

    3. The Role of Hemodynamic Alterations in the Pathogenesis of Diabetic Glomerulopathy

      • Thomas H. Hostetter, Barry M. Brenner
      Pages 81-89

  5. Use and Misuse of Pharmacologic Agents in Kidney Disease

    1. Front Matter

      Pages 91-92
      Download chapter PDF

    2. Prevention of Glomerular Damage with Pharmacologic Agents

      • John P. Hayslett
      Pages 93-99

    3. Prognosis and Prevention of Renal Failure Induced by Toxins

      • John F. Maher
      Pages 101-113

  6. New Insights into Complications of Uremia

    1. Front Matter

      Pages 115-115
      Download chapter PDF

    2. Functional Abnormalities of the Autonomic Nervous System in Uremic and Dialysis Patients

      • Shaul G. Massry, Vito M. Campese
      Pages 117-130

    3. The Pathogenesis, Treatment, and Possible Prevention of Uremic Bone Disease

      • Joseph M. Letteri
      Pages 131-140

  7. Uremia Therapy and the Long-Term Dialysis Patient

    1. Front Matter

      Pages 141-143
      Download chapter PDF

    2. Treatment of Chronic Renal Failure in Seattle

      • Belding H. Scribner
      Pages 145-164
Back to top

Keywords

About this book

Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and demanding group of survivors of a formerly universally fatal disease. Throughout the developed nations of the world, an increasing fraction of the health care budget is devoted to sustaining lives by dialytic therapy and renal transplantation. In the United States, for example, patients in renal failure comprise 0.2% of those eligible for support by Medicare, but consume 5.0% of the Medicare budget. Economic stresses in funding kidney patients have, in some countries such as Great Britain, forced a return to restrictive selection policies abhorrent to empathetic physicians. For third world residents, attention to nutrition, sanitation, and infections such as malaria must take a higher priority than costly uremia therapy. Thus the solution of one problem (retarding death from uremia) created several equally vexing other dilemmas (who should be treated and at what cost?). While sociologists, economists, and ethicists struggle with the new field of psychonephrology,1 a group of investigators and clinicians convened to examine medical aspects of long-surviving treated uremic patients. These proceedings represent the first American analyis of those unique patients who have lived for ten or more years beyond what would have formerly been certain death in uremia.

Editors and Affiliations

  • The Avram Center for Kidney Diseases, Division of Nephrology, The Long Island College Hospital, Brooklyn, USA

    Morrell M. Avram

  • Department of Medicine, Downstate Medical Center, Brooklyn, USA

    Morrell M. Avram

  • Brooklyn Kidney Center and Nephrology Foundation of Brooklyn, Brooklyn, USA

    Morrell M. Avram

Bibliographic Information

  • Book Title: Prevention of Kidney Disease and Long-Term Survival

  • Editors: Morrell M. Avram

  • DOI: https://doi.org/10.1007/978-1-4684-4199-4

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Plenum Publishing Corporation 1982

  • Softcover ISBN: 978-1-4684-4201-4Published: 01 March 2012

  • eBook ISBN: 978-1-4684-4199-4Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: 354

  • Number of Illustrations: 26 b/w illustrations

  • Topics: Infectious Diseases

Publish with us

Policies and ethics

Back to top

Search

Navigation